Business Daily from THE HINDU group of publications
Saturday, June 23, 2007
ePaper
Markets (June 22)
BSE Sensex14467.36 (-31.88)
S&P CNX Nifty4252.05 (-15.35)
US Dollar (Buy/Sell)40.77 (+0.01)


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Subscription

Group Sites

CORPORATE

NEW BUSINESS
Maytas-Gayatri wins AP orders
Gayatri Projects Ltd has informed the BSE that it has secured two orders along with Maytas Infra Ltd under the consortium (Maytas-Gayatri Consortium) with a total projects cost of Rs 880 crore. The contracts pertain to the Outer Ring Road project ... More

COURTS/LEGAL ISSUES
Reliance down on Court order
Shares of Mukesh Ambani-controlled Reliance Industries Ltd slid 1.68 per cent to close at Rs 1,704.05 on the BSE on Friday from the previous close of Rs 1,733.15 in the wake of the Bombay High Court interim order barring the company from selling ... More

IPR
Dabur Pharma plans generic versions of Sanofi's Eloxatin
Oncology specialist Dabur Pharma and Dabur Oncology plc, its UK subsidiary, said that they have submitted two abbreviated new drug applications with Para-IV Certifications for generic versions of Sanofi-Aventis' drug Eloxatin. The company said ... More

MERGERS & ACQUISITIONS
GVK Power picks GVK Aviation
GVK Power & Infrastructure Ltd has informed the BSE that the company has acquired 19.9 lakh equity shares of Rs 10 each for cash at par, aggregating to Rs 1.99 crore in GVK Aviation Pvt Ltd through fresh allotment of shares on .. More

NEW PROJECTS
US non-woven fabrics body plans Indian arm
Online forum launch for breaking tech, market barriers More

AP allots land for JSW project
The Andhra Pradesh Government has allotted land for JSW Ltd to set up an alumina refinery project at S. Kota Mandal in Vizianagaram district. The State Cabinet had cleared the allotment of about 1,048 acres of land for the proposed project ... More

REGULATORY BODIES & RULINGS
Ranbaxy gets tentative USFDA nod for Flomax
Ranbaxy Laboratories has received tentative approval to sell generic version of the Flomax in the US, and is also hopeful of being granted a 180-day marketing exclusivity for it. In a statement, the Gurgaon-based company said that the US Food ... More

ALLIANCES & JOINT VENTURES
Somany Ceramics forms jt venture with Spanish co
Tile manufacturer Somany Ceramics has formed a 50:50 a joint venture with Keraben Ltd of Spain to form Somany Keraben Pvt Ltd to market `Synergy' brand of tiles in India. The joint venture company will initially purchase and import tiles from ... More

SOCIETY & DEVELOPMENT
`Earmark part of IT profits for education, healthcare'
The Chairman of the Amalgamations group of companies, Mr A Sivasailam, today suggested that IT companies should earmark a part of their profits to setting up schools and hospitals for the poor. "We believe it should even be made mandatory to ... More

Naandi drinking water scheme for rural areas
Naandi Foundation, a not-for-profit organisation promoted by Dr Reddy's Laboratories Chairman, Dr K. Anji Reddy, and Satyam Computer chief Mr Ramalinga Raju, has targeted to reach out to 20,000 villages by 2011, offering safe drinking water to ... More

OUTLOOK
Honda plans India-specific small car
2008-model Jazz likely to make its entry More

Transmission: PowerGrid enters bidding mode
The matter has been posed for World Bank support More

Volvo India looks at doubling capacity
Expects more demand for buses as infrastructure develops More

Aptuit to make India its manufacturing base
Global contract drug manufacturing firm Aptuit Inc would shift its manufacturing activity to India in a phased manner following the merger of Hyderabad-based Laurus Labs with Aptuit to form Aptuit Laurus. "Aptuit Laurus facilities in India will ... More

PEOPLE
Tough challenges ahead for Infosys' new CEO
Nilekani appointed co-chairman, S.D. Shibulal COO More

NEW PRODUCTS & SERVICES
Natco Pharma launches oral contraceptive
Hyderabad-based Natco Pharma Ltd has forayed into the oral contraceptive segment with the launch of `Tarana', the first generic version of Yasmine, an international brand from Bayer's. "The foray into the contraceptive segment is in line with ... More

Wyeth launches Tygacil
Pharmaceutical company Wyeth Ltd introduced Tygacil, its novel intravenous antibiotic, in the Indian market on Friday. ``Our new intravenous Tygacil is the first antibiotic in a new class of glycylcyclines, which is quite ... More






Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line

Nifty Companies News
SE Diary
Scoreboard


Related Topics
Alliances & Joint Ventures
Announcements
Auditing
Awards & Honours
Bonus Announcements
Company Law
Corporate Bonds
Corporate Disputes
Corporate Governance
Courts/Legal Issues
Diversification
Environment
Human Resources
Interview
IPOs
IPR
Management
Mergers & Acquisitions
New Projects
Open Offers
Outlook
Outsourcing
Overseas Borrowings
Overseas Investments
People
Performance
Preferential Allotments
Private Placement
Regulatory Bodies & Rulings
Research & Development
Restructuring
Rights Issue
Sick Units
Society & Development
Standards & Benchmarks
Taxation
Trade & Labour Unions


Union Budget 2007-08

Railway Budget 2007-2008

Economic Survey 2006-2007

Top Stories
Google working on search engine with built-in artificial intelligence

FMP calendar gets crowded

Electronics exports up 35% at Rs 1.53 lakh cr

`Further hardening of interest rates unlikely with surplus liquidity'

`Only 10-12% of malls in India successful'

Rising rupee impact: Package likely for exporters soon

Forex reserves up by $1.46 b

Kharif sowing picks up with revival in monsoon activity

SEZ: No notification if land is acquired compulsorily

Looking back
Jun. 10-Jun. 16
`DaimlerChrysler sales not hit by interest rate hikes'

Reliance hopes to have gas price formula in place by July

US corporates outsource legal work to India



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line